Key result
IL-1RA autoantibodies link to vaccine-related myocarditis, multisystem inflammatory syndrome, and IgG4 disease.
Why the study?
Neutralizing autoantibodies targeting IL-1RA are increasingly recognized in conditions like vaccine-related myocarditis, but it remains unclear why only a minority of individuals produce them following COVID-19 or vaccination.
Neutralizing autoantibodies against IL-1RA play a key pathogenic role in several hyperinflammatory conditions, including COVID-19 vaccine-associated myocarditis and MIS-C, by disrupting immune homeostasis.
Answers are grounded in this paper and cite their sources.
IL-1RA autoantibodies may contribute to select hyperinflammatory syndromes; leaves open diagnostic and therapeutic implications pending validation.
The association of neutralizing autoantibodies targeting interleukin-1 receptor antagonist (IL-1RA) with multisystem inflammatory syndrome, IgG4-related disease, and vaccine-related myocarditis is increasingly recognized. The detection of IL-1RA autoantibodies can be notably affected by the techniques and methods employed. Two categories of assays are available: solid-phase immunoassays, which detect binding of IL-1RA autoantibodies, and functional IL-1 signaling reporter cell assays, which offer greater specificity by determining whether circulating autoantibodies can impede interleukin (IL)-1β signal transduction pathways. It is as yet unclear why only a minority of individuals produce pathogenic anti-IL-1RA autoantibodies in response to coronavirus disease 2019 (COVID19) or vaccination. This review article discusses our current knowledge of the process of IL-1RA autoantibody generation, the underlying pathogenesis, detection, and potential treatment strategies for associated diseases.
No takes yet. Share an insight, caveat, or question.
Abdellatif Bouayad (2024) conducted a review in IL-1RA autoantibody-associated diseases (MIS-C, IgG4-related disease, vaccine-related myocarditis). IL-1RA autoantibodies was evaluated. Neutralizing autoantibodies targeting interleukin-1 receptor antagonist (IL-1RA) are increasingly recognized as playing a pathogenic role in multisystem inflammatory syndrome, IgG4-related disease, and vaccine-related myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: